Koroner Arter Baypas Greft Operasyonu Geçiren Bartter Sendromlu Hastada Anestezi Yönetimi

Year 2019, Volume: 22 Issue: 1, 66 - 68, 11.04.2019

Tülay Örki Deniz Avan Serpil Taş

Abstract

Frederic Bartter tarafından ilk kez 1962 yılında tanımlanan Bartter sendromu hipokalemi, metabolik alkaloz,
hiperaldesteronizm, normal kan basıncı ve juxta glomerüler apparatusta hiperplazi ile karakterize nadir
görülen kalıtsal bir hastalıktır. Özellikle açık kalp ameliyatı geçirecek bu hastalarda, asit-baz bozukluğu,
elektrolit imbalansı, intravasküler volüm açığı, vazopressör ilaçlara karşı vasküler duyarsızlık ve trombosit
agregasyonunda defekt gibi bu sendroma ait komplikasyonlar nedeniyle anestezi yönetimi açısından dikkat
gerektirmektedir. Bu olgu sunumunda koroner arter baypas greft operasyonu uygulanan Bartter sendromlu
hastada anestezi yönetimi sunuldu.

Keywords

Bartter sendromu, koroner arter baypas greft, anestezi yönetimi

Anesthesia Management for Coronary Artery Bypass Grafting in a Patient with Bartter Syndrome

Abstract

Bartter syndrome, first described by Frederic Bartter in 1962, is a rare hereditary disease characterized by
hypokalemia, metabolic alkalosis, hyperaldesteronism, normal blood pressure and hyperplasia of the juxtaglomerular apparatus. Complications of Bartter syndrome should be considered during anesthesia management
in patients undergoing open heart surgery, including acid-base disorders, electrolyte imbalance, intravascular
volume deficit, vascular insensitivity to vasopressor drugs and a defect in platelet aggregation. This case report discusses difficulties and challenges in anesthesia management of a patient with Bartter syndrome who
underwent coronary artery by-pass grafting.

Keywords

Bartter syndrome, coronary artery bypass grafting, anesthesia management

References

• 1. Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 1962;33:811-28.
• 2. Vinci JM, Gill JR, Bowden RE, Pisano JJ, Izzo JL, Radfar N, et al. Kallikrein-Kinin System in Bartter Syndrome and Its Response to Prostaglandin Synthetase Inhibition. J Clin Invest 1978;61:1671-82.
• 3. Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992;120:38-43.
• 4. Vetrugno L, Cheli G, Bassi F, Giordano F. Cardiac anesthesia management of a patient with Bartter’s syndrome. J Cardiothorac Vasc Anesth 2005;19:373-6.
• 5. Liaw LC, Banerjee K, Coulthard MG. Dose related growth response to indometacin in Gitelman syndrome. Arch Dis Child 1999;81:508-10.
• 6. Wong KC, Sperry R. What is an acceptable preoperative serum potassium level for surgery? Anesthesiology 1994;81:269.
• 7. Vitez T. Potassium and the anaesthetist. Can J Anaesth 1987;34:30-1.
• 8. Bevan DR. Acute biochemical disorders. In: Vickers MD, Jones RM (eds). Medicine for Anaesthetists. 3rd ed. Oxford: BlaekweU Scientitie Publications, 1989:362-3.
• 9. Gönen H, Türköz A. Bartter sendromlu çocukta anestezi yönetimi. Turkiye Klinikleri J Anest Reanim 2011;9:219-21.